United Kingdom · Seed startup
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$5.6Mraised across 1 round since 2022, from 4 sources
Reported by UCL Technology Fund and 3 others
Missing a round, or an investor who was in one? Tell us.
Bloomsbury Genetic Therapies Limited's investors include UCL Technology Fund, General Catalyst, Index Ventures, MMC Ventures and Target Global, and 1 more on record. UCL Technology Fund led its latest round.
Bloomsbury Genetic Therapies Limited has raised $5.6M across 1 round since 2022.
Bloomsbury Genetic Therapies Limited's most recent round was a Seed of $5.6M in Oct 2022, led by UCL Technology Fund.
Its most recent round, $5.6M in Oct 2022, is also its largest on record.
Bloomsbury Genetic Therapies Limited's first round on record, in Oct 2022, was backed by UCL Technology Fund, General Catalyst and Index Ventures and 3 others.
Bloomsbury Genetic Therapies Limited's latest named round is a Seed, in Oct 2022.
Bloomsbury Genetic Therapies Limited is based in the United Kingdom.
UCL Technology Fund led the Seed in 2022.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
